Introduction and history of polycystic ovary syndrome

Polycystic Ovary Syndrome, Second Edition

Volumn 9780521848497, Issue , 2007, Pages 4-24

  Farquhar, Cindy ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885617546     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545191.002     Document Type: Chapter

References (123)

1. Adams J., Franks S., Polson D.W., et al. (1985) Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 2:1375-1379.
2. Adams J., Polson D.W., and Franks S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. 293:355-359.
3. Adashi E. Y., Resnick C. E., D'Ercole J., Svoboda M. E., and Van Wyk J. J. (1985) Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr. Rev. 6:400-420.
4. Adashi E. Y., Resnick C. E., and Hernandez E. R. (1988) Insulin-like growth factor 1 as an implifier of FSH: studies on mechanism(s) and site(s) of action in cultured rat granulosa cells. Endocrinology 122:1583-1591.
5. Ardaens Y., Robert Y., Lemaitre L., et al. (1991) Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. Fertil. Steril. 55:1062-1068.
6. Balen A. H., Conway G. S., Kaltsas G., et al. (1995) Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients. Hum. Reprod. 10:2107-2111.
7. Barbieri R. L., Makris A., Randall R.W., et al. (1986) Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab. 62:904-910.
8. Barnes R. B., Rosenfield R. L., Burstein S., and Ehrmann D. A. (1989) Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N. Engl. J. Med. 320:559-565.
9. Bayram N., van Wely M., Kaaijk E. M. Bossuyt P. M., and van der Veen F. (2004) Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomized controlled trial. Br. Med. J. 328:192-195.
10. Bergh C., Carlsson B., Olsson J. H., Selleskog U., and Hiullensjo T. (1993) Regulation of androgen production in activated human thecal cells by IGF-1 þ insulin. Fertil. Steril. 59:323-331.
11. Birdsall M., Farquhar C. M., and White H. (1997) Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann. Intern. Med. 126:32-35.
12. Botsis D., Kassanos D., Pyrgiotis E., and Zourlas P. A. (1995) Sonographic incidence of polycystic ovaries in a gynecological population. Ultrasound Obstet. Gynecol. 6:182-185.
13. Bringer J., Lefebvre P., Boulet F., et al. (1993) Body composition and regional fat distribution in polycystic ovarian syndrome: relationship to hormonal and metabolic profiles. Ann. N. Y. Acad. Sci. 687:115-123.
14. Bunker C. B., Newton J. A., Conway G. S., et al. (1991) The hormonal profile of women with acne and polycystic ovaries. Clin. Exp. Derm. 16:420-423.
15. Burghen G. A., Givens J. R., and Kitabehi, A. E. (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 50:113-116.
16. Cara J. F. and Rosenfield R. (1988) Insulin-like growth factor-1 and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 123:733-739.
17. Carey A. H., Chank L., Short F., et al. (1993) Evidence for a single gene eVect causing polycystic ovaries and male pattern baldness. Clin. Endocrinol. (Oxf.) 38:653-658.
18. Chang R. J., Nakamura R. M., Judd H. L., and Kaplan S. A. (1983) Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab. 57:356-359.
19. Chereau A. (1844) Mémoire pur Servir a l'Etude des Maladies des Ovaries. Paris: Fortin, Masson.
20. Clark A. M., Ledger W., Galletly C., et al. (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum. Reprod. 10:2705-2712.
21. Clayton R. N., Ogden V., Hodgkinson J., et al. (1992) How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin. Endocrinol. (Oxf.) 37:127-134.
22. CliVord K., Rai R., Watson H., Franks S., and Regan L. (1996) Randomized controlled trial of pituitary suppression of high LH concentrations in women with recurrent miscarriage. Abstracts 12th Annual Meeting ESHRE, Maastricht: A054.
23. Conway G. S., Honour J.W., and Jacobs H. S. (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin. Endocrinol. (Oxf.) 30:459-470.
24. Conway G. S., Clark P. M., and Wong D. (1993) Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin. Clin. Endocrinol. (Oxf.) 38:219-222.
25. Cresswell J. L., Barker D. J., Osmond C., et al. (1997) Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 351:295-296.
26. Cudmore D.W. and Tupper, W. R. C. (1966) Induction of ovulation with clomiphene citrate: A double-blind study. Fertil. Steril. 17:363-373.
27. Dale O., Tanbo T., Haug E., and Abyholm T. (1998) The impact of insulin resistance on the outcome of ovulation induction with low-dose FSH in women with polycystic ovary syndrome. Hum. Reprod. 13:567-570.
28. Dewailly D. (1997) Definition and significance of polycystic ovaries. Baillière's Clin Obstet Gynaecol. 11:349-368.
29. Dewailly D., Robert Y., Helin I., et al. (1994) Ovarian stromal hypertrophy in hyperandrogenic women. Clin. Endocrinol. (Oxf.) 41:557-562.
30. Donesky B.W. and Adashi E. Y. (1995) Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil. Steril. 63:439-463.
31. Dunaif A. (1992a) Insulin resistance and ovarian hyperandrogenism. Endocrinologist 2:248-260.
32. Dunaif A. (1992b) The Polycystic Ovary Syndrome. Cambridge, MA: Blackwell Scientific.
33. Dunaif A. (1997) Insulin resistance and the polycystic ovarian syndrome: mechanisms and implications for pathogenesis. Endocr. Rev. 18:774-800.
34. Dunaif A., Segal K., Futterweit W., and Dobrjansky A. (1989) Profound peripheral resistance independent of obesity in polycystic ovary syndrome. Diabetes 38:1165-1174.
35. Eden J. A. (1991) The polycystic ovary syndrome presenting as resistant acne successfully treated with cyproterone acetate. Med. J. Austral. 155:677-680.
36. Eden J. A., Place J., Carter G.D., et al. (1989) The diagnosis of polycystic ovaries in subfertile women. Br. J. Obstet. Gynaecol. 96:809-815.
37. Ehrmann D. A. (1997) Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus. Baillière's Clin. Obstet. Gynaecol. 11:335-347.
38. Ehrmann D. A., Barnes R. B., and Rosenfield R. L. (1994) Hyperandrogenism, hirsutism and the polycystic ovary syndrome. In De Groot L. J., Berse M., Burger H. G., et al. (eds.) Endocrinology, 3rd edn, vol. 3, pp. 2093-2112. Philadelphia, PA: W. B. Saunders.
39. El Tabbakh G. H., Lotfy I., Azab I., et al. (1986) Correlation of the ultrasonic appearance of the ovaries in polycystic ovarian disease and the clinical, hormonal, and laparoscopic findings. Am. J. Obstet. Gynecol. 154:892-895.
40. Farquhar C. M., Birdsall M., Manning P., Mitchell J. M., and France J. T. (1994a) The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Austral. N.Z. J. Obstet. Gynaecol. 34:67-72.
41. Farquhar C. M., Birdsall M., Manning P., and Mitchell J. M. (1994b) Transabdominal versus transvaginal ultrasound in the diagnosis of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Ultrasound Obstet. Gynecol. 4:54-59.
42. Farquhar C. M., Williamson K., Gudex G., et al. (2002) A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene resistant polycystic ovarian syndrome. Fertil. Steril. 78:401-411.
43. Farquhar C. M., Williamson K., Brown P. M., et al. (2004) An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate resistant polycystic ovary syndrome. Hum. Reprod. 19:1110-1115.
44. Farquhar C., Vandekerckhove P., and Lilford R. (2005) Laparoscopic "drilling'' by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome (Cochrane Review). In The Cochrane Library, Issue 2. Chichester, UK: John Wiley.
45. Fauser B. C., Pache T.D., Lamberts S.W., et al. (1991) Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. J. Clin. Endocrinol. Metab. 73:811-817.
46. Fauser B. C., Pache T.D., Hop W. C., de Jong F. H., and Dahl K.D. (1992) The significance of a single serum LH measurement in women with cycle disturbance: discrepancies between immunoreactive and bioactive hormone estimates. Clin. Endocrinol. (Oxf.) 37:445-452.
47. Fox R., Corrigan E., Thomas P. A., and Hull M. G. (1991) The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests. Clin. Endocrinol. (Oxf.) 34:127-131.
48. Franks S. (1989) Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. (Oxf.) 31:87-120.
49. Franks S. (1995) Polycystic ovary syndrome. N. Engl. J. Med. 333:853-861.
50. Franks S. and White D. M. (1993) Prevalence of and aetiological factors in polycystic ovary syndrome. Ann. N. Y. Acad. Sci. 687:112-114.
51. Gadir A. A., Mowafi R. S., Alnaser H. M., et al. (1990) Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin. Endocrinol. (Oxf.) 33:585-592.
52. Gemzell C. A., Diczfalusy E., and Tillinger K. G. (1958) Clinical eVect of human pituitary follicle-stimulating hormone (FSH). J. Clin. Endocrinol. Metab. 18:1333.
53. Ginsburg J., Isaacs A. J., Gore M. B. R., and Havard, C.W. H. (1975) Use of clomiphene and luteinizing hormone/follicle stimulating hormone-releasing hormone in investigation of ovulatory failure. Br. Med. J. 3:130-133.
54. Gjoanness, H. (1984) Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil. Steril. 41:20-25.
55. Goldzieher J.W. and Green J. A. (1962) The polycystic ovary. I. Clinical and histological features. J. Clin. Endocrinol. Metab. 22:325-328.
56. Greenblatt E. and Casper R. (1993) Adhesion formation after laparoscopic ovarian cautery for polycystic ovarian syndrome: lack of correlationwith pregnancy rate. Fertil. Steril. 60:766-770.
57. Greenblatt R. B. (1961) Chemical induction of ovulation. Fertil. Steril. 12:402.
58. Guzick D. S., Talbott E.O., Sutton-Tyrrell K., et al. (1996) Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am. J. Obstet. Gynecol. 174:1224-1229.
59. Hague W. M., Adams J., Reeders S. T., Peto T. E., and Jacobs H. S. (1988) Familial polycystic ovaries: a genetic disease. Clin. Endocrinol. (Oxf.) 29:593-605.
60. Hamilton-Fairley D., Kiddy D., Watson H., Sagle M., and Franks S. (1991) Low dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum. Reprod. 6:1095-1099.
61. Hamilton-Fairley D., Kiddy D., Watson H., Paterson C., and Franks S. (1992) Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br. J. Obstet. Gynaecol. 99:128-131.
62. Homburg R. (1996) Polycystic ovary syndrome: from gynaecological curiosity to multisystem endocrinopathy. Hum. Reprod. 11:29-39.
63. Homburg R. (1998) Adverse eVect of luteinizing hormone on fertility: fact or fantasy. Baillière's Clin. Obstet. Gynaecol. 12:555-563.
64. Homburg R. (2003) The management of infertility associated with polycystic ovary syndrome. Reprod. Biol. Endocrinol. 1:109.
65. Homburg R., Armar N. A., Eshel A., Adams J., and Jacobs H. S. (1988) Influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br. Med. J. 297:1024-1026.
66. Homburg R., Pariente C., Lunenfeld B., and Jacobs H. S. (1992) The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGF-BP-1) in the pathogenesis of polycystic ovary syndrome. Hum. Reprod. 7:1379-1383.
67. Hughes E., Collins J., and Vandekerckhove P. (1999a) Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotrophin for clomiphene-resistant polycystic ovary syndrome (Cochrane Review). In The Cochrane Library, Issue 1. Oxford, UK: Update Software.
68. Hughes E., Collins J., and Vandekerckhove P. (1999b) Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene resistant polycystic ovarian syndrome (Cochrane Review). In The Cochrane Library, Issue 1. Oxford, UK: Update Software.
69. Hull M. G. (1987) Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol. Endocrinol. 1:235-245.
70. Insler V., Potashnik G. Lunenfeld E., Meizner I., and Levy J. (1988) Ovulation induction with hMG following down regulation of the pituitary-ovarian axis by LH-RH analogues. Gynecol. Endocrinol. 2:67.
71. Jacobs H. S. (1996) Polycystic ovary syndrome: the present position. Gynecol. Endocrinol. 10:427-433.
72. Khan C. R., Flier J. S., Bar R. S., Archal J. A., and Gorden P. (1976) The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man. N. Engl. J. Med. 294:739-745.
73. Kiddy D. S., Hamilton-Fairley D., Bush A., et al. (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 36:105-111.
74. Kistner R.W. (1966) Use of clomiphene citrate, human chorionic gonadotropin, and human menopausal gonadotropin for induction of ovulation in the human female. Fertil. Steril. 17:569.
75. Lazovic G., Milacic D., Terzic M., et al. (1998) Medicaments or surgical therapy of PCOS. Fertil. Steril. 70:472.
76. Li T. C., Saravelos H., Chow M. S., Chisabingo R., and Cooke I.D. (1998) Factors aVecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility. Br. J. Obstet. Gynaecol. 105:338-344.
77. Liddell H., Farquhar C. M., and Sowden C. (1997). The association of polycystic ovaries and recurrent miscarriage. N. Z. Med. J. 37:402-406.
78. Lobo R. A., Granger L., Goebelsmann U., and Mishell J. R. (1981) Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotrophin secretion in women with PCO. J. Clin. Endocrinol. Metab. 52:156-158.
79. Lord J., Flight I. H., and Norman R. J. (2003) Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Br. Med. J. 327:951-953.
80. Lowe P., Kovacs G., and Howlett D. (2005) Incidence of polycystic ovaries and polycystic ovary syndrome amongst women inMelbourne, Australia. Austral. N. Z. J. Obstet. Gynaecol. 45:17-19.
81. Lunde O., Magnus P., Sandvik L., and Hoglo S. (1989) Familial clustering in the polycystic ovarian syndrome. Gynecol. Obstet. Invest. 28:23-30.
82. MacLeod S. C., Mitton D. M., Parker A. S., and Tupper W. R. C. (1970) Experience with induction of ovulation. Am. J. Obstet. Gynecol. 1:814-824.
83. McArthur J.W., Ingersoll F.W., andWorcester J. (1958) The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system. J. Clin. Endocrinol. Metab. 18:1202-1215.
84. Michelmore K., Balen A., Dunger D., et al. (1998) Prevalence and clinical features of polycystic ovary syndrome in 224 young female volunteers. Hum. Reprod. 13: abstract 0024.
85. Nestler J. E. (1997) Insulin regulation of human ovarian androgens.Hum.Reprod. 12(Suppl.):52-62.
86. Orsini L. F., Venturoli S., and Lorusso R. (1985) Ultrasonic findings in polycystic ovarian disease. Fertil. Steril. 43:709-714.
87. Pasquali R., Antenucci D., Casmirri F., et al. (1989) Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J. Clin. Endocrinol. Metab. 68:173-179.
88. Pasquali R., Casimirri F., and Venturoli D. (1994) Body fat distribution has weight-independent eVects on clinical, hormonal and metabolic features of women with polycystic ovary syndrome. Metabolism 6:706-713.
89. Plymate S. R., Fariss B. L., Basset M. L., and Matej L. (1981) Obesity and its role in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 66:1246-1248.
90. Polson D.W., Mason H.D., Saldahna M. B., and Franks S. (1987) Ovulation of a single dominant follicle during treatment with low dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 26:205-212.
91. Polson D.W., Adams J., Wadsworth J., and Franks S. (1988) Polycystic ovaries: a common finding in normal women. Lancet 16(April):870-872.
92. Rai R., CliVord K., and Regan L. (1996) The modern preventative treatment of recurrent miscarriage. Br. J. Obstet. Gynaecol. 103:106-110.
93. Rajkhowa M., Glass M. R., Rutherford A. J., Michelmore K., and Balen A. H. (2000) Polycystic ovary syndrome: a risk factor for cardiovascular disease? Br. J. Obstet. Gynaecol. 107:11-18.
94. Rebar R., Judd H. L., Yen S. C. C., et al. (1976) Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest. 57:1320-1329.
95. Recombinant Human FSH Study Group (1995) Clinical assessment of recombinant human follicle-stimulating ovarian follicle development before in vitro fertilization. Fertil. Steril. 63:77-86.
96. Regan L., Owen E. J., and Jacobs H. S. (1990) Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet 336:1141-1144.
97. Robinson S., Rodin D. A., Deacon A., Wheeler M. J., and Clayton R. N. (1992) Which hormone tests for the diagnosis of polycystic ovary syndrome? Br. J. Obstet. Gynaecol. 99:232-238.
98. Rosenfield R. L., Barnes R. B., Cara J. F., and Lucky A.W. (1990) Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil. Steril. 53:785-791.
99. Sagle M., Bishop K., Ridley N., et al. (1988) Recurrent early miscarriage and polycystic ovaries. Br. Med. J. 297:1027-1028.
100. Sagle M. A., Hamilton-Fairley D., Kiddy D. S., and Franks S. (1991) A comparative randomized study of low dose human menopausal gonadotropin and follicle stimulating hormone in women with polycystic ovarian syndrome. Fertil. Steril. 55:56-60.
101. Santon R. J. and Bardin C.W. (1973) Episodic LH secretion in man: pulse analysis, clinical interpretation, physiologic mechanisms. J. Clin. Invest. 52:2617-2628.
102. Saxton D.W., Farquhar C. M., Rae T., et al. (1990) Accuracy of ultrasound measurements of female pelvic organs. Br. J. Obstet. Gynaecol. 97:695-699.
103. Seibel M. M., Kamrava M. M., McArdle C., and Taymor M. L. (1984) Treatment of polycystic ovarian disease with chronic low dose follicle stimulating hormone: biochemical changes and ultrasound correlation. Int. J. Fertil. 29:39-43.
104. Shoham Z. and Insler V. (1996) Recombinant technique and gonadotropins production: new era in reproductive medicine. Fertil. Steril. 66:187-201.
105. Shoham Z., Patel A., and Jacobs H. S. (1991) Polycystic ovary syndrome: safety and eVectiveness of stepwise and low dose administration of purified follicle stimulating hormone. Fertil. Steril. 55:1051-1056.
106. Shoupe D., Kumar D.D., and Lobo R. A. (1983) Insulin resistance in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 147:588-592.
107. Stein I. F. and Leventhal M. L. (1935) Amenorrhoea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol. 29:181-191.
108. Stein I. F., Cohen M. R., and Elson R. E. (1948) Results of bilateral ovarian wedge resection in 47 cases of sterility. Am. J. Obstet. Gynecol. 58:267-273.
109. Swanson M., Sauerbrei E. E., and Cooperberg P. L. (1981) Medical implications of ultrasonically detected polycystic ovaries. J. Clin. Ultrasound 9:219-222.
110. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81:19-25.
111. Thomas A., Okamoto S., O'Shea F., et al. (1989) Do raised serum luteinizing hormone levels during stimulation for in-vitro fertilization predict outcome? Br. J. Obstet. Gynaecol. 96:1328-1332.
112. Thompson C. R. and Hansen L. M. (1970) Pergonal (menotropins): a summary of clinical experience in the induction of ovulation and pregnancy. Fertil. Steril. 21:844-853.
113. Tulppala M., Stenman U. H., Cacciatore B., and Ylikorkala O. (1993) Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women. Br. J. Obstet. Gynaecol. 100:348-352.
114. Vallisneri A. (1721) Cited in Insler and Lunesfeld (1990) Gynecol. Endocrinol. 4:51-69.
115. van Wely M., Bayram N., Bossunyt P. M. M., et al. (2004) An economic comparison of a laparoscopic electrocoagulation strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome. Hum. Reprod. 19:1741-1745.
116. Vegetti W., Ragni G., Baroni E., et al. (1998) Laparoscopic ovarian drilling versus low-dose pure FSH in anovulatory clomiphene-resistant patients with polycystic ovarian syndrome: randomized prospective study. Abstracts 14th Annual Meeting ESHRE, Goteborg: A120.
117. Waldstreicher J., Santoro N. F., Hall J. E., Filicori M., and Crowley Jr. W. F. (1988) Hyperfunction of the hypothalamic pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotrope desensitization. J. Clin. Endocrinol. Metab. 66:165-172.
118. Wang C. F. and Gemzell C. (1980) The use of human gonadotropins for induction of ovulation in women with polycystic ovarian disease. Fertil. Steril. 33:479-486.
119. Wild R. A. (1997) Cardiovascular and lipoprotein abnormalities in androgen excess. In Azziz R., Nestler J. E., and Dewailly D. (eds.) Androgen Excess Disorders in Women pp. 681-688. Philadelphia, PA: Lippincott-Raven.
120. Willis D. and Franks, S. (1995) Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J. Clin. Endocrinol. Metab. 80:3788-3790.
121. Yen S. S. C. (1980) The polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 12:177-207.
122. Yen S. S. C. (1983) Clinical application of gonadotropin releasing hormone analogues. Fertil. Steril. 39:257.
123. Yen S. S. C., Vela P., and Rankin J. (1970) Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 30:435-442.